individu
inflammatori
rheumat
diseas
requir
special
consider
regard
coronaviru
diseas
caus
sever
acut
respiratori
syndrom
coronaviru
mani
individu
consid
atrisk
seriou
infect
due
immunocompromis
state
result
underli
immun
condit
use
tar
gete
immunemodul
therapi
biolo
gic
howev
diseasemodifi
drug
commonli
use
treat
rheumat
diseas
hydroxychloro
quin
investig
potenti
therapi
commonli
use
therapi
biolog
target
interleukin
il
eg
tocilizumab
sarilumab
eg
anakinra
assess
patient
subsequ
develop
patholog
immun
respons
includ
cytokin
storm
eg
reactiv
haemophagocyt
lymphohistiocytosi
whether
background
immunosuppress
medic
put
individu
rheumat
diseas
increas
decreas
risk
sever
infect
unknown
evid
lack
guid
treatment
decis
gener
understand
char
acter
istic
popul
urgent
need
inform
manag
guidelin
identifi
highrisk
individu
pandem
need
data
answer
key
clinic
que
tion
quickli
realis
coordin
global
scale
rheumatologist
research
patient
rheumat
diseas
despit
recognis
trackrecord
highqual
observ
drug
safeti
research
rheumatolog
within
multipl
nation
biolog
registri
immedi
data
come
would
need
collect
address
demand
therefor
inter
nation
rheumatolog
com
muniti
mobilis
unpreced
pace
creat
global
rheumatolog
allianc
less
week
global
rheumatolog
allianc
success
develop
onlin
portal
case
report
form
enabl
healthcar
provid
around
world
enter
inform
individu
rheumat
diseas
diagnos
registri
data
element
includ
provid
name
citi
countri
clinic
individu
patientlevel
sociodemograph
inform
includ
age
sex
race
ethnic
data
regard
rheumat
di
eas
captur
includ
medic
diagnosi
diseas
activ
comorbid
inform
ill
includ
diag
nosi
date
symptom
treatment
outcom
admiss
hospit
maximum
level
care
eg
need
supplement
oxygen
invas
ventil
laboratori
result
coinfect
concentr
leucopenia
also
collect
avail
due
intern
data
legisl
particular
european
gener
data
protect
regul
parallel
data
entri
point
one
limit
european
leagu
rheumat
eular
particip
countri
limit
site
global
launch
data
entri
point
link
secur
redcap
survey
platform
host
univers
manchest
manchest
uk
univers
california
san
francisco
ucsf
san
francisco
ca
usa
provid
submit
data
individu
rheumat
diseas
diagnos
individu
patient
consent
requir
registri
determin
human
subject
research
uk
health
research
author
univers
manchest
us
feder
guidelin
ucsf
sever
institut
april
individu
rheumat
diseas
diag
nose
includ
six
conti
nent
europ
north
america
south
america
asia
africa
oceania
summari
data
associ
individu
shown
tabl
present
proofofprincipl
global
cooper
rapid
collect
data
intern
crisi
possibl
within
week
launch
registri
rheumatolog
provid
around
world
submit
data
case
allow
preliminari
characterisa
tion
rapid
dissemin
inform
regard
individu
rheumat
diseas
time
registri
aim
examin
differ
sever
outcom
sociodemograph
rheumat
diseas
characterist
medic
taken
diagnosi
global
data
entri
point
see
rheumcovidorgproviderglob
medic
administ
diagnosi
data
serv
inform
treatment
strategi
better
characteris
individu
increas
risk
infect
strength
global
rheumatolog
allianc
registri
includ
global
represent
individu
rheumat
diseas
increas
power
evid
base
examin
import
risk
factor
outcom
expect
major
contribut
global
rheumatolog
allianc
rapid
dissemin
inform
sinc
exist
nation
patient
registri
might
less
equip
captur
data
global
scale
given
fix
timepoint
restrict
consent
new
individu
registri
without
limit
includ
potenti
select
bia
toward
sever
case
mani
countri
individu
sever
symptom
test
rheumatologist
report
case
also
extrem
pressur
work
outsid
rheumatolog
provid
frontlin
medic
care
patient
might
unabl
report
case
report
might
delay
duplic
entri
might
occur
across
differ
provid
although
data
analyt
team
care
examin
address
data
qualiti
regular
basi
also
despit
includ
individu
across
world
specif
adjust
analys
might
possibl
due
sampl
size
final
whole
denomin
individu
rheumat
diseas
acquir
unknown
databas
unabl
provid
accur
estim
risk
specif
outcom
across
entir
rheumat
diseas
popul
associ
specif
treatment
time
exist
patient
registri
administr
databas
provid
data
like
current
pandem
end
thu
strengthen
current
critic
role
databas
summari
global
rheumatolog
allianc
repres
commit
rheumatologist
gener
rapid
data
help
inform
care
individu
rheumat
diseas
use
immunomodul
therapi
inform
databas
provid
time
respons
realworld
data
larg
literatur
gap
exist
inform
provid
treatment
pattern
individu
diagnos
offer
better
understand
possibl
risk
factor
associ
sever
outcom
rheumat
diseas
popul
mag
klh
contribut
equal
pmm
jy
contribut
equal
jy
pr
design
direct
studi
mag
klh
data
analys
author
contribut
equal
data
interpret
write
final
approv
manuscript
mag
support
us
nation
institut
health
niam
